Forskning ved Københavns Universitet - Københavns Universitet

Forside

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Gavin Giovannoni
  • Giancarlo Comi
  • Stuart Cook
  • Kottil Rammohan
  • Peter Rieckmann
  • Sørensen, Per Soelberg
  • Patrick Vermersch
  • Peter Chang
  • Anthony Hamlett
  • Bruno Musch
  • Steven J Greenberg
  • CLARITY study group
Cladribine provides immunomodulation through selective targeting of lymphocyte subtypes. We report the results of a 96-week phase 3 trial of a short-course oral tablet therapy in patients with relapsing-remitting multiple sclerosis.
OriginalsprogEngelsk
TidsskriftNew England Journal of Medicine
Vol/bind362
Udgave nummer5
Sider (fra-til)416-26
Antal sider11
ISSN0028-4793
DOI
StatusUdgivet - 4 feb. 2010

ID: 34093028